Cargando…
Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies
Background: New technologies constitute an important cost-driver in healthcare, but the dynamics that lead to their emergence remains poorly understood from a health policy standpoint. The goal of this paper is to clarify how entrepreneurs, investors, and regulatory agencies influence the value of e...
Autores principales: | Lehoux, Pascale, Miller, Fiona A., Daudelin, Geneviève, Denis, Jean-Louis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kerman University of Medical Sciences
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5582437/ https://www.ncbi.nlm.nih.gov/pubmed/28949463 http://dx.doi.org/10.15171/ijhpm.2017.11 |
Ejemplares similares
-
The Conceptualization of Value in the Value Proposition of New Health Technologies : Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies"
por: Buttigieg, Sandra C., et al.
Publicado: (2017) -
The Bright Elusive Butterfly of Value in Health Technology Development: Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies"
por: Greenhalgh, Trisha, et al.
Publicado: (2017) -
New Health Technologies: A UK Perspective: Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies"
por: Parvizi, Nassim, et al.
Publicado: (2017) -
Why Learning How to Chase Butterflies Matters: A Response to Recent Commentaries
por: Lehoux, Pascale, et al.
Publicado: (2017) -
Regulation A+: how the JOBS Act creates opportunities for entrepreneurs and investors
por: Getty, Paul M, et al.
Publicado: (2015)